ER asthma drug trial aims to cut relapses by 50%
NCT ID NCT07166939
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times
Summary
This study tests whether giving the inhaler Airsupra to adults in the emergency department, instead of usual care, can prevent asthma flare-ups and improve control over the next 3 months. About 1,860 people aged 18 to 54 with acute asthma will take part. The goal is to see if starting this medicine early reduces urgent doctor visits and helps patients manage their asthma better at home.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MetroHealth
RECRUITINGCleveland, Ohio, 44109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.